Dermatology

Filter

Stapokibart Shows Safety and Efficacy in Children with Atopic Dermatitis

Stapokibart Shows Safety and Efficacy in Children with Atopic Dermatitis

November 2025

A phase 1b/2a trial reports that stapokibart is well tolerated and improves symptoms in children aged 6–11 years with moderate-to-severe atopic dermatitis.

Psoriasis and Hidden Inflammation: A Cardiovascular Risk Uncovered

In this study, researchers examined three international cohorts of patients with moderate-to-severe psoriasis undergoing biologic therapy.

Could Severe Atopic Dermatitis Increase Heart Disease Risk?

Pure atopic dermatitis patients had a significantly higher prevalence of cardiovascular disease compared to those with atopic comorbidities

Increasing UV Exposure and Rising Melanoma Risk in Canada

Young adults (18–29 years) had the highest UV exposure and sunburn rates, and were least likely to use protective clothing.

Skin Bacteria Shape Immune Response to UV Light

Interestingly, UVB exposure and topical application of cis-UCA led to changes in the skin’s microbial composition.

Managing Anxiety and Depression in Atopic Dermatitis Care

Mental health issues such as anxiety and depression are common comorbidities in people with atopic dermatitis.

Ivarmacitinib Shows Promise in Treating Severe Eczema

The results demonstrated significantly greater improvement in the ivarmacitinib groups compared to placebo.

Hyperbaric Oxygen Therapy for Radiation-Induced Dermatitis

Discover a study that evaluated the effectiveness of hyperbaric oxygen therapy for radiation-induced dermatitis.

Oral Nutraceutical Shows Promise for Treating Acne

A study has shed new light on a novel approach to managing acne vulgaris, highlighting the efficacy of an oral nutraceutical.

Loading posts...

« Previous 1 … 10 11 12 13 14 … 41 Next »